Both tumor and stroma regions play important roles in the LUSC stratification, which could be confirmed by the tumor-specific subtype associations for several immune-related markers, including PD-L1, CD3, and CD8, being retained in the stroma-specific subtypes. The gene discussed is CD8A; the disease is neoplasm.